Diagnostic note
Peer reviewed

Performance of a Mycoplasma hyopneumoniae serum ELISA for antibody detection in processing fluids

Ronaldo Magtoto, PhD; Betsy Armenta-Leyva, DVM; Precy Dizon-Magtoto, DVM, MS; Ting-Yu Cheng, DVM, PhD; Maria J. Clavijo, DVM, PhD; Clayton Johnson, DVM; Will Lopez, DVM, PhD; David Baum, DVM, PhD; Jeffrey Zimmerman, DVM, PhD; Luis G. Giménez-Lirola, PhD

Summary

The diagnostic performance of a commercial Mycoplasma hyopneumoniae (MHP) serum enzyme-linked immunosorbent assay (ELISA) was evaluated for MHP antibody detection in processing fluids (n = 494) using samples from three commercial swine farms. Based on historical monitoring, one farm was considered MHP positive and two were considered MHP negative. Samples were tested at a 1:10 dilution and diagnostic sensitivities and specificities estimated for specific ELISA sample-to-positive (S:P) cutoffs. At S:P ≥ 0.40, diagnostic sensitivity and specificity were estimated as 97.6% and 100.0%, respectively. Overall, the results suggest that processing fluids can be used for MHP antibody surveillance in breeding herds.

Keywords: swine, Mycoplasma hyopneumoniae, processing fluid, enzyme-linked immunosorbent assay, diagnostic performance

Received: May 28, 2021
Accepted:
October 20, 2021

Resumen — Comportamiento de un ELISA para suero de Mycoplasma hyopneumoniae para la detección de anticuerpos en fluidos de proceso

Se evaluó el comportamiento diagnóstico de un ensayo inmunoabsorbente ligado a enzimas (ELISA) en suero de Mycoplasma hyopneumoniae (MHP) comercial para la detección de anticuerpos contra MHP en fluidos de proceso (n = 494) utilizando muestras de tres granjas porcinas comerciales. Con base en el monitoreo histórico, una granja se consideró positiva para MHP y dos negativas para MHP. Las muestras se analizaron a una dilución de 1:10, y las sensibilidad y especificidad de diagnóstico se estimaron para los puntos de corte específicos de muestra a positivo (S:P) de ELISA. Con S:P ≥ 0.40, la sensibilidad y especificidad diagnóstica se estimaron en 97.6% y 100.0%, respectivamente. En general, los resultados sugieren que los fluidos de proceso se pueden utilizar para la vigilancia de anticuerpos MHP en hatos reproductores.

Résumé — Performances d’un ELISA sérique pour la détection d’anticorps envers Mycoplasma hyopneumoniae dans les fluides de procédures

Les performances diagnostiques d’une épreuve immuno-enzymatique (ELISA) sérique commerciale envers Mycoplasma hyopneumoniae (MHP) ont été évaluées pour la détection d’anticorps MHP dans les fluides de procédures (n = 494) à l’aide d’échantillons provenant de trois fermes porcines commerciales. Sur la base de la surveillance historique, une ferme a été considérée comme positive au MHP et deux ont été considérées comme négatives au MHP. Les échantillons ont été testés à une dilution de 1:10 et les sensibilités et spécificités diagnostiques ont été estimées pour des seuils ELISA spécifiques échantillon-à-positif (S:P). À S:P ≥ 0.40, la sensibilité et la spécificité diagnostiques ont été estimées à 97.6% et 100.0%, respectivement. Dans l’ensemble, les résultats suggèrent que les fluides de procédures peuvent être utilisés pour la surveillance des anticorps MHP dans les troupeaux reproducteurs.


Mycoplasma hyopneumoniae (MHP), the etiological agent of enzootic pneumonia1 and a major player in the porcine respiratory disease complex,2 is one of the most economically important pathogens of swine, costing the US swine industry approximately $400 million annually.3 Sow herd stability is key to the reduction of MHP losses in growing pigs because piglets are born MHP-free and become infected by contact with sows shedding the microorganism.4 For this reason, control programs typically focus either on enhancement of sow herd immunity (vaccination or intentional gilt exposure) or complete elimination of MHP. Regardless of the approach, testing for MHP-specific DNA or antibody is needed to establish the status of the breeding herd population.5,6 Because each diagnostic approach has its advantages and disadvantages, the choice is determined by which best fits the farm’s MHP control strategy and yet is practical in terms of sampling and testing.

Processing fluid (PF), the serosanguineous fluid recovered from testicles and tails at the time of piglet processing (3-5 days of age), is an easily collected specimen with high diagnostic utility.7-10 Sow herd surveillance using PF was first reported11 in 2010 and has been widely adopted by the industry, eg, the Iowa State University Veterinary Diagnostic Laboratory performed approximately 395 diagnostic tests on processing fluids in 2017; 11,790 tests in 2018; 22,411 tests in 2019; 22,163 tests in 2020; and 26,075 tests in 2021 (Dr Giovani Trevisan, DVM, email, January 15, 2022). Although Boettcher et al11 reported the detection of MHP-specific (colostral) antibody in PF collected from piglets ≤ 7 days of age, there are no reports substantiating or expanding upon this initial report. Therefore, the purpose of this study was to evaluate the diagnostic performance (ie, sensitivity and specificity) of a commercial enzyme-linked immunosorbent assay (ELISA) for the detection of MHP antibodies using PF samples.

Methods

Design

Processing fluid samples (n = 494) from 3 commercial farms were tested for the presence of MHP antibodies using a commercial MHP indirect serum antibody ELISA at a 1:10 dilution. Based on intervention program and historical monitoring, one farm was considered MHP positive (246 PF samples) and two farms were considered MHP negative (248 samples). Receiver operating characteristic (ROC) curve analysis was used to analyze diagnostic performance using farm MHP status as a proxy of sample status. From this analysis, diagnostic sensitivity and specificity and 95% CI were estimated over a range of cutoffs.

PF samples

Samples were collected from 3 commercial swine farms from 2018 through 2020 for the purpose of monitoring porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV). The criteria to establish MHP status corresponded to the MHP status of gilts used for the original stocking at each farm. The status of the MHP-negative farms was established based on their stocking history (ie, stocked with confirmed naïve gilts) and syndromic and routine surveillance. The latter consisted of monthly serum collection tested by MHP ELISA. Neither MHP-negative farm implemented MHP vaccine for piglets, gilts, or sows. The MHP-positive herd was stocked with MHP-positive gilts (confirmed at stocking via MHP ELISA on serum) that received commercial MHP vaccine at weaning (4 weeks of age; 2 mL Circumvent PCV-M; Merck Animal Health USA) and again at prebreeding (20 weeks of age; 2 mL Circumvent PCV-M). There was no mass vaccination of the sow herd and the piglets did not receive any MHP vaccine prior to weaning. Clinical signs of MHP in that herd were only identified sporadically in the gilt development unit in gilts 15 to 20 weeks of age, including mild coughing for 2 to 3 weeks with no noticeable performance impact (no mortality or average daily gain concerns).

Sample collection was performed by farm personnel using procedures previously described.9 In brief, PF samples were collected at the time of piglet processing (ie, castration and tail docking) by placing testicle and tail tissues on gauze suspended over the top of a plastic container, thereby allowing the tissue exudate to pool in the bottom of the container. Each PF sample included tissues from 14 to 56 litters of 3- to 5-day-old piglets. At the end of processing, the liquid was transferred to a tube, stored at approximately 4°C, sent to the Iowa State University Veterinary Diagnostic Laboratory for PCV2 and PRRSV PCR testing, and then stored at -20°C until tested for MHP antibody.

MHP indirect antibody ELISA

The MHP ELISA (M hyo Ab test; Idexx Laboratories Inc), an assay designed to detect anti-P46 antibodies in serum, was used in the study. Samples were thawed, allowed to reach room temperature, and briefly vortexed. Thereafter, samples were tested for the presence of MHP antibodies following the instructions provided by the manufacturer with the exception that samples were tested at a 1:10 dilution rather than the 1:40 dilution described for serum.

To perform the test, samples were diluted 1:10 by adding 15 µL of sample to 135 µL of kit diluent in a dilution plate. Thereafter, 100 µL of diluted samples were transferred to plate wells, after which the plates were incubated (30 minutes, 22°C) on a plate heater (16-Position Microtiter Plate Heater; J-KEM Scientific) and then washed four times with 350 µL of wash solution on a plate washer (ELx405 Biotek Instruments Inc). Then 100 µL of kit conjugate was added to each well and the plate incubated (30 minutes, 22°C). The wash cycle was then repeated, 100 µL of 3,3’,5,5’-Tetramethylbenzidine substrate was added to each well, the plates incubated (15 minutes, 22°C), and then 100 µL of stop solution was added into each well. Plates were read on an ELISA reader (EMax Plus Microplate Reader; Molecular Devices) using SoftMax pro 7.0 Software (Molecular Devices) and optical density (OD) results converted to sample-to-positive (S:P) ratios:

MHP ELISA S:P = (Sample OD – Negative control mean OD) / (Positive control mean OD – Negative control mean OD)

Statistical analysis

Diagnostic sensitivities and specificities for specific ELISA S:P cutoffs were estimated by ROC analysis using R software12 (version 4.0.3; The R Foundation) and pROC package.13 To perform the analysis, MHP ELISA S:P results with negative values were truncated to zero and sample status (positive, negative) was assumed to match farm status (MHP positive or MHP negative). Estimation of 95% CI for diagnostic sensitivity and specificity for every ELISA S:P cutoff was performed using a nonparametric stratified bootstrapping method with 10,000 iterations.13,14

Results

A frequency distribution of MHP ELISA S:P responses by farm status is given in Figure 1 and a summary of test responses by farm and year is given in Table 1. Among all samples from the two MHP-negative farms (n = 248), 246 (99.2%) had S:P values < 0.20 and all 248 (100%) had S:P values < 0.40. Among samples from the MHP-positive farm (n = 246), 240 (97.6%) had S:P values ≥ 0.40. Table 2 lists the diagnostic sensitivity and specificity estimated for specific MHP ELISA S:P cutoffs and 95% CI.

Figure 1: Frequency distribution of MHP antibody ELISA (IDEXX Laboratories Inc) S:P responses by farm MHP status. MHP = Mycoplasma hyopneumoniae; ELISA = enzyme-linked immunosorbent assay; S:P = sample-to-positive ratio.
Figure 1
Table 1: Summary of MHP antibody ELISA* processing fluid sampling and testing data by farm
Farm
(MHP status)
Year No. samples MHP ELISA mean S:P (min, max)
1 (positive) 2018 39 0.80 (0.10, 1.40)
2019 143 1.51 (0.24, 2.61)
2020 64 2.11 (1.18, 2.73)
Total 246 1.55 (0.10, 2.73)
2 (negative) 2018 33 0.01 (0.0, 0.06)
2019 122 0.03 (0.0, 0.28)
2020 49 0.03 (0.0, 0.14)
Total 204 0.03 (0.0, 0.28)
3 (negative) 2018 38 0.03 (0.0, 0.13)
2019 6 0.05 (0.02, 0.09)
Total 44 0.03 (0.0, 0.13)

*   M hyo Ab test (IDEXX Laboratories Inc) with processing fluid samples tested at a 1:10 dilution.

MHP = Mycoplasma hyopneumoniae; ELISA = enzyme-linked immunosorbent assay; S:P = sample-to-positive ratio.

Table 2: Processing fluid MHP antibody ELISA* diagnostic sensitivity and specificity by S:P cutoff
S:P cutoff Sensitivity, % (95% CI) Specificity, % (95% CI)
0.1 99.6 (98.8-100) 94.4 (91.5-97.2)
0.2 99.2 (98.0-100) 99.2 (98.0-100)
0.3 98.8 (97.2-100) 100 (100-100)
0.4 97.6 (95.5-99.2) 100 (100-100)
0.5 95.5 (92.7-98.0) 100 (100-100)
0.6 93.9 (90.7-96.7) 100 (100-100)
0.7 90.7 (87.0-93.9) 100 (100-100)
0.8 88.6 (84.6-92.3) 100 (100-100)
0.9 83.7 (78.9-88.2) 100 (100-100)
1.0 79.7 (74.8-84.6) 100 (100-100)

*  M hyo Ab test (IDEXX Laboratories Inc) with processing fluid samples tested at a 1:10 dilution.

  Diagnostic sensitivity and specificity point estimates derived from ROC analysis using R software12 (version 4.0.3) and pROC package.13 A 95% CI was calculated using a nonparametric stratified bootstrapping method with 10,000 iterations.13,14

MHP = Mycoplasma hyopneumoniae; ELISA = enzyme-linked immunosorbent assay; S:P = sample-to-positive ratio.

Discussion

Routine surveillance based on DNA and antibody detection is crucial for tracking MHP in commercial herds.15 In sow herds, serum antibody testing is a common approach, but serum-based MHP surveillance is constrained both by the labor required for collecting blood samples and the number of samples required for statistically valid surveillance.15 However, other specimens have been described to contain detectable levels of MHP antibody and could potentially be used for surveillance, eg, colostrum, milk, muscle tissue exudates (meat juice), and processing fluids.11,16-18 In this regard, processing fluids are of particular interest because they are easily collected10 and achieve better detection at the population level at a lower cost than individual pig sampling.7,10,19

The use of processing fluid antibody testing for sow herd surveillance was first reported in 2010 and has since been described for the nucleic acid- or antibody-based surveillance of a variety of pathogens, including hepatitis E,7 influenza A virus,11 MHP,11,20 PRRSV,9,11,21,22 PCV2,8,22,23 porcine delta coronavirus,22 and Salmonella enterica.11

On a diagnostic timeline, processing fluids were preceded by use of meat juice samples and the two are similar in derivation, ie, both are tissue exudates. Like processing fluids, meat juice contains detectable antibodies against a variety of pathogens, eg, Toxoplasma gondii,24 pseudorabies virus,25 Salmonella enterica,26 PRRSV,27 porcine epidemic diarrhea virus,28 Yersinia enterocolitica, and Actinobacillus pleuropneumoniae.17 Pertinent to the current study, Meemken et al17 reported a 91% diagnostic sensitivity and 96% specificity for MHP antibody detection in meat juice when compared to serum antibody.

Processing fluids and meat juice differ in the source of the antibody in the sample. Antibody in meat juice is derived from the pig from which the sample was collected and indicates that the pig had been infected by, or vaccinated for, the pathogen of interest.29 In contrast, antibody in processing fluids from 3- to 5-day-old piglets primarily represents circulating maternal antibody (primarily IgG). That is, colostral IgG is transported from the piglet’s intestinal tract and into the lamina propria by nonselective endocytosis, then enters the intestinal lymphatic system, and finally, the circulatory system.30 Therefore, antibody detection in processing fluid samples provides the means to surveil sow herd MHP antibody status - not the piglet humoral immune response against MHP infection.

Consistent with the report by Boettcher et al,11 the commercial MHP ELISA used in this study was performed using a processing fluid sample dilution of 1:10 rather than the 1:40 dilution used in serum testing. The initial study of MHP antibody in 181 sows and processing fluids from their litters described strong agreement in MHP ELISA results at the herd level.11 However, surveillance requires the use of assays with known diagnostic performance. The present study determined that the manufacturer´s recommended cutoff (S:P ≥ 0.40) provided 97.6% (95% CI, 95.5%-99.2%) and 100.0% (95% CI, 100%-100%) diagnostic sensitivity and specificity, respectively. However, since near-perfect diagnostic specificity to minimize false-positive results is important for surveillance,31 users may elect to use a higher cutoff using the cutoffs and associated diagnostic sensitivities and specificities provided in Table 2.

One limitation of the study was that sample classification was based on farm status rather than individual sow status. Two distinctly different MHP antibody response patterns were observed in samples from MHP-negative vs MHP-positive farms, but it is possible that samples from the MHP-positive sow herd were negative for MHP antibodies. Notably, four samples from the MHP-positive herd had S:P values < 0.40 (Figure 1). The overall impact of this small number of misclassified samples on the analysis would be to slightly underestimate the diagnostic sensitivity of the ELISA, but this will have little impact on the utility of this population-based surveillance tool. Still, the lack of detection in the MHP-negative dataset suggests a high level of specificity of this sample type and test. The MHP ELISA cannot differentiate between vaccine or acquired antibodies. Thus, positive processing fluid samples used from this study may have resulted from the use of vaccine in the breeding herd and not maternal antibodies derived from natural infection. This point will need to be considered for routine surveillance of vaccinated but antigen-free herds.

Overall, this study demonstrated that processing fluids could be used for detection of MHP-specific antibodies. The diagnostic performance of the sample type in known status samples revealed a high level of accuracy. The convenience and low-cost nature afforded by processing fluids, combined with its potentially high herd sensitivity, make it highly promising for monitoring naïve herds. Future investigation would need to determine the sensitivity of this sample type compared to serum or deep tracheal swabs for timely detection of MHP antibodies in MHP-naïve herds.

Implications

Under the conditions of this study:

  • The MHP antibody ELISA discriminated between negative and positive sow herds.
  • An S:P cutoff ≥ 0.40 provided 98.8% sensitivity and 100% specificity.
  • Processing fluids could be used for surveillance of MHP-naïve herds.

Acknowledgments

Conflict of interest

Dr Zimmerman serves as a consultant to Idexx Laboratories, Inc. The terms of the consulting arrangement have been reviewed and approved by Iowa State University in accordance with its conflict of interest policies. No other conflicts reported.

Disclaimer

Scientific manuscripts published in the Journal of Swine Health and Production are peer reviewed. However, information on medications, feed, and management techniques may be specific to the research or commercial situation presented in the manuscript. It is the responsibility of the reader to use information responsibly and in accordance with the rules and regulations governing research or the practice of veterinary medicine in their country or region.

References

1. Maes D, Verdonck M, Deluyker H, de Kruif A. Enzootic pneumonia in pigs. Vet Q. 1996;18:104-109. https://doi.org/10. 10880/01652176.1996.9694628

2. Brockmeier S, Halbur PG, Thacker EL. Porcine respiratory disease complex. In: Brogden KA, Guthmiller JM, eds. Polymicrobial Diseases. ASM Press; 2002:231-258.

*3. Holtkamp D. Economic impact of Mycoplasma hyopneumoniae on pig farms. Pig 333. Published September 19, 2014. Accessed April 08, 2021. https://www.pig333.com/articles/economic-impact-of-mycoplasmahyopneumoniae-on-pig-farms_8936/

4. Maes D, Sibila M, Kuhnert P, Segalés J, Haesebrouck F, Pieters M. Update on Mycoplasma hyopneumoniae infections in pigs: Knowledge gaps for improved disease control. Transbound Emerg Dis. 2018;65(Suppl 1):110-124. https://doi.org/10.1111/tbed.12677

5. Sibila M, Pieters M, Molitor T, Maes D, Haesebrouck F, Segalés J. Current perspectives on the diagnosis and epidemiology of Mycoplasma hyopneumoniae infection. Vet J. 2009;181(3):221-231. https://doi.org/10.1016/j.tvjl.2008.02.020

6. Clavijo MJ, Galina Pantoja L, Holtkamp DJ, Yeske P, Johnson C, Sprague M, Fano E, Main R, McDowell E, Painter T, Becton L, Baumert D, Glowzenski L, Snelson H, Maschhoff A. Establishing Mycoplasma hyopneumoniae herd status classification criteria for breeding herds. J Swine Health Prod. 2021;29:319-326.

7. Di Bartolo I, De Sabato L, Chelli E, Alborali GL, Tonni M, Monini M, De Lucia A, Ostanello F. Pilot investigation on the presence of anti-Hepatitis E Virus (HEV) antibodies in piglet processing fluids. Animals. 2020;10(7):1168. https://doi.org/10.3390/ani10071168

8. Künzli F, Sydler T, Lewis F, Brugnera E, Sidler X. Suitability of testicular tissue fluid from castrated piglets to verify sow-vaccination status and herd monitoring. Schweiz Arch Tierheilkd. 2020;162(7):463-470. https://doi.org/10.17236/sat00267

9. López WA, Angulo J, Zimmerman JJ, Linhares DCL. Porcine reproductive and respiratory syndrome monitoring in breeding herds using processing fluids. J Swine Health Prod. 2018;26(3):146-150.

10. Lopez WA. Strengthening porcine reproductive and respiratory syndrome virus (PRRSV) detection in breeding herds: Development and assessment of processing fluids sampling strategies. Thesis. Iowa State University; 2020. https://doi.org/10.31274/etd-20200624-225

*11. Boettcher J, Hensch A, Gangl A, Janowetz B, Alex M, Niemeyer H, Wittkowski G. Testicles of castrated piglets an anachronism – but powerful sample for disease surveillance in sow herds. In: Proceedings of the 21st IPVS Congress. International Pig Veterinary Society; 2010:304.

*12. R Core Team. R: A language and environment for statistical computing [computer program]. Version 4.0.3. Vienna, Austria: R Foundation for Statistical Computing; 2020. https://www.R-project.org

13. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, Müller M. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77. https://doi.org/10.1186/1471-2105-12-77

14. Carpenter J, Bithell J. Bootstrap confidence intervals: When, which, what? A practical guide for medical statisticians. Stat Med. 2000;19:1141-1164. https://doi.org/10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F

15. Clavijo MJ, Hu D, Krantz S, Cano JP, Maróstica TP, Henao-Diaz A, Poeta Silva APS, Hemker D, Tapia E, Zimmerman S, Fano E, Polson D, Fitzgerald R, Tucker A, Main R, Wang C, Zimmerman JJ, Rotolo ML. Mycoplasma hyopneumoniae surveillance in pig populations: Establishing sampling guidelines for detection in growing pigs. J Clin Microbiol. 2021;59(5):e03051-20. https://doi.org/10.1128/JCM.03051-2024

16. Jenvey CJ, Reichel MP, Cockcroft PD. Erysipelothrix rhusiopathiae and Mycoplasma hyopneumoniae: The sensitivities of enzyme-linked immunosorbent assays for detecting vaccinated sows of unknown disease status using serum and colostrum, and the correlation of the results for sow serum, colostrum, and piglet serum. J Vet Diagn Invest. 2015;27(2):211-216. https://doi.org/10.1177/1040638714568111

17. Meemken D, Tangemann A, Meermeier D, Gundlach S, Mischok D, Greiner M, Klein G, Blaha T. Establishment of serological herd profiles for zoonoses and production diseases in pigs by “meat juice multi-serology”. Prev Vet Med. 2014;113(4):589-598. https://doi.org/10.1016/j.prevetmed.2013.12.006

18. Rautiainen EJ. Mycoplasma hyopneumoniaeAspects of epidemiology, protection and control. Dissertation. University of Helsinki; 2001. http://hdl.handle.net/10138/18966

19. Trevisan G, Jablonski E, Angulo J, Lopez WA, Linhares DCL. Use of processing fluid samples for longitudinal monitoring of PRRS virus in herds undergoing virus elimination. Porcine Health Manag. 2019;5(1):18-15. https://doi.org/10.1186/s40813-019-0125-x

20. Vilalta C, Sanhueza JM, Murray D, Johnson L, Pieters M. Detection of Mycoplasma hyopneumoniae in piglet processing fluids. Vet Rec. 2019;185(16):510. https://doi.org/10.1136/vr.105475

21. de Almeida MN, Corzo CA, Zimmerman JJ, Linhares DCL. Longitudinal piglet sampling in commercial sow farms highlights the challenge of PRRSV detection. Porcine Health Manag. 2021;7(10):31. https://doi.org/10.1186/s40813-021-00210-5

*22. Trevisan G, Angulo J, Johnson C, Jensen M, Utrera V, Marostica T, Gauger P, Linhares DCL. Increasing the functionality of your processing fluid toolbox beyond PRRSV monitoring: PCV2, PEDV, and PDCoV. In: Proceedings of the 51st AASV Annual Meeting. American Association of Swine Veterinarians; 2020:27-28.

*23. López W, Linhares DCL. Processing fluids, blood serum and tail blood swabs to detect PRRSV RNA and PCV2 DNA by PCR-based assays. In: ISU James D. McKean Swine Disease Conference. Iowa State University; 2017:69.

24. Hagiwara T, Katsube Y. Detection of Toxoplasma infection in pork by Sabin-Feldman’s dye test with meat extract. Nihon Juigaku Zasshi. 1981;43:763-765. https://doi.org/10.1292/jvms1939.43.763

25. Le Potier MF, Fournier A, Houdayer C, Hutet E, Auvigne V, Hery D, Sanaa M, Toma B. Use of muscle exudates for the detection of anti-IgE antibodies to Aujeszky’s disease virus. Vet Rec. 1998;143(14):385-387. https://doi.org/10.1136/vr.143.14.385

26. Nielsen B, Ekeroth L, Bager F, Lind P. Use of muscle fluid as a source of antibodies for serologic detection of Salmonella infection in slaughter pig herds. J Vet Diagn Invest. 1998;10(2):158-163. https://doi.org/10.1177/104063879801000207

27. Mortensen S, Strandbygaard B, Bøtner A, Feld N, Willeberg P. Monitoring porcine reproductive and respiratory syndrome virus infection status in swine herds based on analysis of antibodies in meat juice samples. Vet Res. 2001;32(5):441-453. https://doi.org/10.1051/vetres:2001136

28. Poonsuk K, Cheng T-Y, Ji J, Zimmerman J, Giménez-Lirola L. Detection of porcine epidemic diarrhea virus (PEDV) IgG and IgA in muscle tissue exudate (“meat juice”) specimens. Porcine Health Manag. 2018;4:31. https://doi.org/10.1186/s40813-018-0107-4

29. Yeo S, Yang M, Nyachoti M, Rauh R, Callahan JD, Nfon C. Detection of foot-and-mouth disease virus in swine meat juice. Pathogens. 2020;9(6):424-434. https://doi.org/10.3390/pathogens9060424

30. Poonsuk K, Zimmerman JJ. Historical and contemporary aspects of maternal immunity in swine. Anim Health Res Rev. 2018;19(1):31-45. https://doi.org/10.1017/S1466252317000123

31. Rydevik G, Innocent GT, McKendrick IJ. Evaluating diagnostic tests with near-perfect specificity: Use of a Hui–Walter approach when designing a trial of a DIVA test for bovine Tuberculosis. Front Vet Sci. 2018;5:192. https://doi.org/10.3389/fvets.2018.00192

* Non-refereed references.


RM, BA-L, T-YC, MJC, WL, DB, JZ, LGG-L: College of Veterinary Medicine, Iowa State University, Ames, Iowa.

PD-M: College of Veterinary Medicine, Pampanga State Agricultural University, Magalang, Pampanga, Philippines.

CJ: Carthage Veterinary Service, Ltd, Carthage, Illinois.

MJC, WL: PIC North America, Hendersonville, Tennessee.

Corresponding author: Dr Luis Giménez-Lirola, 2652 College of Veterinary Medicine, 1800 Christensen Drive, Iowa State University, Ames, IA 50011; Tel: 515-294-7025; Email: luisggl@iastate.edu.

Magtoto R, Armenta-Leyva B, Dizon-Magtoto P, Cheng T-Y, Clavijo MJ, Johnson C, Lopez W, Baum D, Zimmerman J, Giménez-Lirola LG. Performance of a Mycoplasma hyopneumoniae serum ELISA for antibody detection in processing fluids. J Swine Health Prod. 2022;30(3):165-170. https://doi.org/10.54846/jshap/1265

Portable Document Format PDF version

RIS citation RIS citation (download for bibliography management software)